Regeneron Prescription drugs mentioned it might purchase 23andMe, which filed for chapter in March and would proceed to supply client DNA testing providers.
23andMe To Be Purchased by Regeneron Prescription drugs, a Biotech Firm, for $256 Million
Related Posts
Add A Comment